Showing 1 - 4 results of 4 for search 'Mary Jo Lechowicz', query time: 0.02s Refine Results
  1. 1
    Nivolumab-associated cutaneous T-cell lymphoma

    Nivolumab-associated cutaneous T-cell lymphoma by Jennifer A. Marks, MD, Douglas C. Parker, MD, L. Crain Garrot, MD, Mary Jo Lechowicz, MD

    Published 2021-03-01
    Get full text
    Article
  2. 2
    Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature

    Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature by Joshua D Preston, Caroline S Jansen, Siddhartha Kosaraju, Tim Niyogusaba, Tony Z Zhuang, Sally W Iwamoto, Spencer K Hutto, Mary Jo Lechowicz, Pamela B Allen

    Published 2023-12-01
    Get full text
    Article
  3. 3
    Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab

    Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab by Sarah A. Westergaard, MD, Mary Jo Lechowicz, MD, Maggie Harrington, NP-C, Justin Elsey, BS, Jack L. Arbiser, MD, PhD, Mohammad K. Khan, MD

    Published 2020-08-01
    Get full text
    Article
  4. 4
    Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma

    Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma by Auris Huen, Bradley M. Haverkos, Jasmine Zain, Ramchandren Radhakrishnan, Mary Jo Lechowicz, Sumana Devata, Neil J. Korman, Lauren Pinter-Brown, Yasuhiro Oki, Prajak J. Barde, Ajit Nair, Kasi Viswanath Routhu, Srikant Viswanadha, Swaroop Vakkalanka, Swaminathan P. Iyer

    Published 2020-08-01
    Get full text
    Article

Search Tools: